The Biggest 3 Holders Of Advaxis, Inc. (ADXS)

Advaxis, Inc. (NASDAQ:ADXS) is on recovery track with 8.33% gain from a 1-year low price of $1.80. The company lost -11.76% to attain the price of $1.95 on 03/13/2018. Throughout the recent session, the prices were hovering between $1.75 and $1.96. These shares are 1002.56% off its target price of $21.5 and the current market capitalization stands at $74.72M. The recent change has given its price a -26.45% deficit over SMA 50 and -79.58% deficit over its 52-week high. The stock witnessed -25.86% declines, -34.78% declines and -71.49% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ADXS’s volatility during a week at 9.93% and during a month it has been found around 7.43%.

Advaxis, Inc. (ADXS) Top Holders

Institutional investors currently hold around $34 million or 39.6% in ADXS stock. Look at its top three institutional owners. Adage Capital Partners Gp, L.L.C. owns $8.84 million in Advaxis, Inc., which represents roughly 11.83% of the company’s market cap and approximately 26% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 2,281,216 shares of the stock are valued at $5.04 million. The third largest holder is Vanguard Group Inc, which currently holds $4.34 million worth of this stock and that ownership represents nearly 5.81% of its market capitalization.

Advaxis, Inc. 13F Filings

At the end of 12/31/2017 reporting period, 43 institutional holders increased their position in Advaxis, Inc. (NASDAQ:ADXS) by some 2,509,252 shares, 40 decreased positions by 4,474,221 and 26 held positions by 8,261,442. That puts total institutional holdings at 15,244,915 shares, according to SEC filings. The stock grabbed 16 new institutional investments totaling 666,849 shares while 19 institutional investors sold out their entire positions totaling 1,172,058 shares.

Advaxis, Inc. (NASDAQ:ADXS) Insider Trades

Multiple company employees have indulged in significant insider trading. Advaxis, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Interim CEO Lombardo Anthony A has sold 32 shares of Advaxis, Inc. (ADXS) in trading session dated Feb. 02, 2018. These shares are worth $94 and were traded at $2.93 each. The SEC filing shows that Bonstein Sara performed a sale of 5,224 shares. The CFO disposed these shares by way of transaction on Jan. 03, 2018. The company’s shares were given away at $3.18 per share worth to an income of some $16,612 on account of Bonstein Sara.

CFO, Bonstein Sara, sold 3,862 common shares of Advaxis, Inc. (ADXS) in the open market. In a transaction dated Nov. 06, 2017, the shares were put up for sale at an average price of $3.3, raking in a sum of $12,745. After this sale, 227,908 common shares of ADXS are directly owned by the insider, with total stake valued at $444,421.

In the transaction dated Nov. 06, 2017, the great number of shares disposed came courtesy the Chief Scientific Officer; Petit Robert disposed a total of 3,723 shares at an average price of $3.3, amounting to approximately $12,286. The insider now directly owns 220,917 shares worth $430,788.

Advaxis, Inc. (ADXS) Analyst Guide

Several analysts have released their opinion on Advaxis, Inc. (NASDAQ:ADXS), with 3 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.

Previous articleGuru Analysis Of Myriad Genetics, Inc. (MYGN)
Next articlePacific Ethanol, Inc. (PEIX): A Detailed Look at its Institutional Ownership